455 related articles for article (PubMed ID: 16111569)
1. Anemia, tumor hypoxemia, and the cancer patient.
Varlotto J; Stevenson MA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):25-36. PubMed ID: 16111569
[TBL] [Abstract][Full Text] [Related]
2. Management of anemia in patients undergoing curative radiotherapy. Erythropoietin, transfusions, or better nothing?
Dunst J
Strahlenther Onkol; 2004 Nov; 180(11):671-81. PubMed ID: 15549184
[TBL] [Abstract][Full Text] [Related]
3. [Anemia impact on treatments of cervical carcinomas].
Marchal C; Rangeard L; Brunaud C
Cancer Radiother; 2005 Mar; 9(2):87-95. PubMed ID: 15820436
[TBL] [Abstract][Full Text] [Related]
4. rHuEPO and improved treatment outcomes: potential modes of action.
Blackwell K; Gascón P; Sigounas G; Jolliffe L
Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.
Crawford J
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):41-53. PubMed ID: 12380954
[TBL] [Abstract][Full Text] [Related]
6. Cancer-related anemia and recombinant human erythropoietin--an updated overview.
Bohlius J; Weingart O; Trelle S; Engert A
Nat Clin Pract Oncol; 2006 Mar; 3(3):152-64. PubMed ID: 16520805
[TBL] [Abstract][Full Text] [Related]
7. Anemia in cancer patients: significance, epidemiology, and current therapy.
Tchekmedyian NS
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):17-24. PubMed ID: 12380951
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?
Harrison L; Blackwell K
Oncologist; 2004; 9 Suppl 5():31-40. PubMed ID: 15591420
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia.
Vaupel P; Dunst J; Engert A; Fandrey J; Feyer P; Freund M; Jelkmann W
Onkologie; 2005 Apr; 28(4):216-21. PubMed ID: 15840971
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cancer-related anemia.
Badzek S; Curić Z; Krajina Z; Plestina S; Golubić-Cepulić B; Radman I
Coll Antropol; 2008 Jun; 32(2):615-22. PubMed ID: 18756919
[TBL] [Abstract][Full Text] [Related]
11. [Anemia and radiotherapy].
Pasquier D; Lartigau E
Bull Cancer; 2003 Apr; 90 Spec No():S152-7. PubMed ID: 12856427
[TBL] [Abstract][Full Text] [Related]
12. [Updating 1999 of Standards, Options and Recommendations (SOR) for the clinical use of erythropoietin in oncology. FEDERATION OF THE FRENCH CANCER CENTRES (FNCLCC)].
Spaëth D; Marchal C; Bataillard A; Blanc-Vincent MP
Bull Cancer; 1999; 86(7-8):631-9. PubMed ID: 10477381
[TBL] [Abstract][Full Text] [Related]
13. The blue cross blue shield assessment technology review: summary of findings.
Bennett CL
Best Pract Res Clin Haematol; 2005; 18(3):423-31. PubMed ID: 15792916
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
[TBL] [Abstract][Full Text] [Related]
15. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option.
Cornes P; Coiffier B; Zambrowski JJ
Curr Med Res Opin; 2007 Feb; 23(2):357-68. PubMed ID: 17288690
[TBL] [Abstract][Full Text] [Related]
17. [Standards, Options, and Recommendations for using erythropoietin in cancerology].
Spaëth D; Marchal C; Blanc-Vincent MP
Bull Cancer; 1998 Apr; 85(4):337-46. PubMed ID: 9752298
[TBL] [Abstract][Full Text] [Related]
18. Pre and peri-operative erythropoietin for reducing allogeneic blood transfusions in colorectal cancer surgery.
Devon KM; McLeod RS
Cochrane Database Syst Rev; 2009 Jan; (1):CD007148. PubMed ID: 19160325
[TBL] [Abstract][Full Text] [Related]
19. Improved recurrence-free survival with ARCON for anemic patients with laryngeal cancer.
Janssens GO; Rademakers SE; Terhaard CH; Doornaert PA; Bijl HP; van den Ende P; Chin A; Takes RP; de Bree R; Hoogsteen IJ; Bussink J; Span PN; Kaanders JH
Clin Cancer Res; 2014 Mar; 20(5):1345-54. PubMed ID: 24452791
[TBL] [Abstract][Full Text] [Related]
20. rHuEPO and treatment outcomes: the preclinical experience.
Ludwig H
Oncologist; 2004; 9 Suppl 5():48-54. PubMed ID: 15591422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
